....a competitive patent portfolio of Regenics technology in US, EU and RoW.......


10 years of IP work secures exclusive rights to use salmon roe technology from wound healing, psoriasis, atopical dermatitis to 3D bioprinting and skin diseases.

Most recent IP news!

Overview of patent portfolio (September 2017):


For inquiries on patents, trademarks, Intellectual propery, content, distribution, ownership and permissions, please contact Regenics AS

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.